Karen Meerovitch
Corporate Officer/Principal bei Mimetogen Pharmaceuticals, Inc.
Profil
Karen Meerovitch is currently working as a Senior Director-Clinical Development at Mimetogen Pharmaceuticals, Inc. She previously worked as a Senior Scientist at Shire BioChem, Inc. from 1997 to 2002.
She also worked as a Group Leader-Cancer & Infectious Disease at Avance Pharma, Inc. Dr. Meerovitch completed her undergraduate and doctorate degrees at McGill University and her graduate degree at the University of Alberta.
Aktive Positionen von Karen Meerovitch
| Unternehmen | Position | Beginn |
|---|---|---|
Mimetogen Pharmaceuticals, Inc.
 Mimetogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mimetogen Pharmaceuticals, Inc. develops peptidomimetic small molecule drugs against glaucoma and cancer. Its product mimic the effects of neurotrophin proteins that help to maintain the health and growth of cells and tissues found in the eye. Mimetogen provides tyrosine kinase agonists that prevent neuronal death; small molecule tyrosine kinase receptor agonists, which stimulates mucin secretion from conunctival goblet cells; and small molecule neurotrophin mimetics that rescues retinal pigment epithelial cells from oxidative stress-induced apoptosis. The company was founded by Garth Cumberlidge and H. Uri Saragovi in 2005 and is headquartered in Montreal, Canada. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Karen Meerovitch
| Unternehmen | Position | Ende |
|---|---|---|
Shire BioChem, Inc.
 Shire BioChem, Inc. Medical DistributorsDistribution Services Shire BioChem, Inc. provides pharmaceutical sales and marketing services in Canada. The company is headquartered in Laval, Canada. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2002 |
Avance Pharma, Inc.
 Avance Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avance Pharma, Inc. manufactures and distributes pharmaceutical products. It provides drugs for the treatment of infectious diseases, cancer and other illnesses. The company's products include enzymes, seratrodats, allergic drugs, vaccines and antihypertensive drugs. Avance Pharma was founded by Jean Archambault in December, 1997 and is headquartered in Laval, Canada. | Corporate Officer/Principal | - |
Ausbildung von Karen Meerovitch
| McGill University | Doctorate Degree |
| University of Alberta | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Shire BioChem, Inc.
Shire BioChem, Inc. Medical DistributorsDistribution Services Shire BioChem, Inc. provides pharmaceutical sales and marketing services in Canada. The company is headquartered in Laval, Canada. | Distribution Services |
Avance Pharma, Inc.
Avance Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avance Pharma, Inc. manufactures and distributes pharmaceutical products. It provides drugs for the treatment of infectious diseases, cancer and other illnesses. The company's products include enzymes, seratrodats, allergic drugs, vaccines and antihypertensive drugs. Avance Pharma was founded by Jean Archambault in December, 1997 and is headquartered in Laval, Canada. | Health Technology |
Mimetogen Pharmaceuticals, Inc.
Mimetogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mimetogen Pharmaceuticals, Inc. develops peptidomimetic small molecule drugs against glaucoma and cancer. Its product mimic the effects of neurotrophin proteins that help to maintain the health and growth of cells and tissues found in the eye. Mimetogen provides tyrosine kinase agonists that prevent neuronal death; small molecule tyrosine kinase receptor agonists, which stimulates mucin secretion from conunctival goblet cells; and small molecule neurotrophin mimetics that rescues retinal pigment epithelial cells from oxidative stress-induced apoptosis. The company was founded by Garth Cumberlidge and H. Uri Saragovi in 2005 and is headquartered in Montreal, Canada. | Health Technology |
